• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中药治疗非糜烂性反流病的疗效与安全性:一项随机对照试验的Meta分析

Efficacy and Safety of Traditional Chinese Medicine on Nonerosive Reflux Disease: A Meta-Analysis of Randomized Controlled Trials.

作者信息

Xiao Jiao, Yang Yunfeng, Zhu Yuanrong, Qin Yan, Li Yifan, Fu Mengjie, Zhai Zhengdong, Zhu Lingyun

机构信息

Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China.

Fenglin Community Health Service Center of Xuhui District, Shanghai 200030, China.

出版信息

Evid Based Complement Alternat Med. 2018 May 24;2018:1505394. doi: 10.1155/2018/1505394. eCollection 2018.

DOI:10.1155/2018/1505394
PMID:29977310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5994284/
Abstract

OBJECTIVES

Traditional Chinese medicine (TCM) therapy for nonerosive reflux disease (NERD) remains controversial. The aim of this study was to evaluate the efficacy and safety of TCM regimens in NERD treatment.

METHODS

Randomized controlled trials (RCTs) of TCM treatment for NERD through September 31, 2017, were systematically identified in PubMed, Wanfang Data, CNKI, VIP, CBM, Ovid, Web of Science, and Cochrane Library databases. Quality assessment was performed by employing the Cochrane Risk of Bias assessment tool.

RESULTS

A total of 725 and 719 patients in 14 RCTs were randomly divided into TCM alone and conventional Western medicine groups, respectively. The clinical total effective rate of the TCM group was markedly higher than that of the single proton pump inhibitors (PPIs) or Prokinetics therapy group (RR = 1.19, 95% CI = 1.07-1.31, and = 0.0008), while it was comparable to that of the combination of PPIs and Prokinetics therapy group (RR = 1.14, 95% CI = 1.00-1.29, and = 0.05). Compared with Western medicine group, the TCM group showed improved symptom relief through a reduced RDQ score (SMD = -0.91; 95% CI = -1.68--0.15; and = 0.02). Additionally, TCM clearly decreased the recurrence rate (RR = 0.38, 95% CI = 0.28-0.52, and < 0.00001). Adverse events, such as constipation, sickness, fever, abdominal distension, and stomach noise, were slight for both the TCM and Western medicine groups and disappeared after the easement of pharmacological intervention; in particular, TCM possessed fewer side effects.

CONCLUSION

Compared with PPIs or Prokinetics therapy alone, TCM single therapy can better improve the clinical total effective rate and symptom relief and decrease the recurrence rate and adverse events in the treatment of NERD. Our results suggest that TCM will be a promising alternative therapy for NERD patients in the future.

摘要

目的

中医治疗非糜烂性反流病(NERD)仍存在争议。本研究旨在评估中医方案治疗NERD的疗效和安全性。

方法

通过在PubMed、万方数据、中国知网、维普资讯、中国生物医学文献数据库、Ovid、科学引文索引数据库和考克兰图书馆数据库中系统检索,找出截至2017年9月31日关于中医治疗NERD的随机对照试验(RCT)。采用考克兰偏倚风险评估工具进行质量评估。

结果

14项RCT中的725例和719例患者分别被随机分为单纯中医组和传统西医组。中医组的临床总有效率显著高于单质子泵抑制剂(PPI)或促动力药治疗组(RR = 1.19,95%CI = 1.07 - 1.31,P = 0.0008),而与PPI和促动力药联合治疗组相当(RR = 1.14,95%CI = 1.00 - 1.29,P = 0.05)。与西医组相比,中医组通过降低反流疾病问卷(RDQ)评分改善了症状缓解情况(标准化均数差= -0.91;95%CI = -1.68 - -0.15;P = 0.02)。此外,中医明显降低了复发率(RR = 0.38,95%CI = 0.28 - 0.52,P < 0.00001)。便秘、恶心、发热、腹胀和胃鸣等不良事件在中医组和西医组中均较轻微,且在药物干预缓解后消失;特别是中医的副作用更少。

结论

与单独使用PPI或促动力药治疗相比,中医单一疗法在治疗NERD时能更好地提高临床总有效率和症状缓解程度,并降低复发率和不良事件。我们的结果表明,中医在未来将成为NERD患者一种有前景的替代疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8289/5994284/512aa8a14b60/ECAM2018-1505394.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8289/5994284/e7d76cf4785c/ECAM2018-1505394.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8289/5994284/aae907d62d22/ECAM2018-1505394.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8289/5994284/f120877a948c/ECAM2018-1505394.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8289/5994284/2c857b81aac0/ECAM2018-1505394.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8289/5994284/1c01311a4275/ECAM2018-1505394.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8289/5994284/512aa8a14b60/ECAM2018-1505394.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8289/5994284/e7d76cf4785c/ECAM2018-1505394.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8289/5994284/aae907d62d22/ECAM2018-1505394.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8289/5994284/f120877a948c/ECAM2018-1505394.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8289/5994284/2c857b81aac0/ECAM2018-1505394.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8289/5994284/1c01311a4275/ECAM2018-1505394.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8289/5994284/512aa8a14b60/ECAM2018-1505394.006.jpg

相似文献

1
Efficacy and Safety of Traditional Chinese Medicine on Nonerosive Reflux Disease: A Meta-Analysis of Randomized Controlled Trials.中药治疗非糜烂性反流病的疗效与安全性:一项随机对照试验的Meta分析
Evid Based Complement Alternat Med. 2018 May 24;2018:1505394. doi: 10.1155/2018/1505394. eCollection 2018.
2
Add-On Therapy with Traditional Chinese Medicine Improves Outcomes and Reduces Adverse Events in Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials.中药辅助治疗改善肝细胞癌的预后并减少不良事件:一项随机对照试验的荟萃分析
Evid Based Complement Alternat Med. 2017;2017:3428253. doi: 10.1155/2017/3428253. Epub 2017 Jun 7.
3
Systematic review of randomized controlled trials of traditional Chinese medicine treatment of non-acute bronchial asthma complicated by gastroesophageal reflux.系统评价中医药治疗非急性支气管哮喘合并胃食管反流的随机对照试验。
J Tradit Chin Med. 2012 Mar;32(1):12-8. doi: 10.1016/s0254-6272(12)60025-9.
4
Meta-Analysis on the Efficacy and Safety of Traditional Chinese Medicine as Adjuvant Therapy for Refractory Androgenetic Alopecia.中药作为难治性雄激素性脱发辅助治疗的疗效和安全性的Meta分析
Evid Based Complement Alternat Med. 2019 Oct 31;2019:9274148. doi: 10.1155/2019/9274148. eCollection 2019.
5
Efficacy and safety of the Chinese herbal formula Hewei Jiangni recipe for NERD with cold-heat complex syndrome: study protocol for a double-blinded randomized controlled trial.和胃降逆方治疗寒热错杂型食管反流病的有效性和安全性:一项双盲随机对照试验的研究方案。
Trials. 2021 Aug 18;22(1):545. doi: 10.1186/s13063-021-05471-7.
6
Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis.中药治疗特发性肺纤维化的疗效与安全性:一项荟萃分析
Evid Based Complement Alternat Med. 2020 Feb 12;2020:1752387. doi: 10.1155/2020/1752387. eCollection 2020.
7
Efficacy and Safety of Traditional Chinese Herbal Medicine for Antipsychotic-Related Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.中药治疗抗精神病药物所致便秘的疗效与安全性:一项随机对照试验的系统评价和Meta分析
Front Psychiatry. 2021 Apr 29;12:610171. doi: 10.3389/fpsyt.2021.610171. eCollection 2021.
8
A systematic review of outcomes in COVID-19 patients treated with western medicine in combination with traditional Chinese medicine versus western medicine alone.一项关于在西药联合中医药治疗与单纯西药治疗的 COVID-19 患者结局的系统评价。
Expert Rev Mol Med. 2022 Jan 6;24:e5. doi: 10.1017/erm.2021.35.
9
Efficacy and safety of traditional Chinese medicine for Tourette's syndrome: A meta-analysis of randomized controlled trials.中医药治疗抽动秽语综合征的疗效和安全性:一项随机对照试验的荟萃分析。
Asian J Psychiatr. 2020 Jan;47:101853. doi: 10.1016/j.ajp.2019.101853. Epub 2019 Oct 24.
10
Oral traditional Chinese medication for adhesive small bowel obstruction.口服中药治疗粘连性小肠梗阻。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD008836. doi: 10.1002/14651858.CD008836.pub2.

引用本文的文献

1
Efficacy and safety of Jianpi Qinghua granules for non-erosive reflux disease with spleen deficiency and damp-heat syndrome: a multicenter, randomized, double-blind, placebo-controlled clinical trial.健脾清化颗粒治疗脾虚湿热型非糜烂性反流病的疗效与安全性:一项多中心、随机、双盲、安慰剂对照临床试验
Front Nutr. 2025 Jan 7;11:1509931. doi: 10.3389/fnut.2024.1509931. eCollection 2024.
2
Herbal medicine for the treatment of non-erosive reflux disease: A systematic review and meta-analysis.草药治疗非糜烂性反流病:系统评价和荟萃分析。
Medicine (Baltimore). 2024 Nov 8;103(45):e40269. doi: 10.1097/MD.0000000000040269.
3

本文引用的文献

1
Gastroesophageal Reflux Disease.胃食管反流病
Prim Care. 2017 Dec;44(4):561-573. doi: 10.1016/j.pop.2017.07.001. Epub 2017 Oct 5.
2
Adverse Event Reporting for Proton Pump Inhibitor Therapy: An Overview of Systematic Reviews.质子泵抑制剂治疗的不良事件报告:系统评价概述
Otolaryngol Head Neck Surg. 2016 Oct;155(4):547-54. doi: 10.1177/0194599816648298. Epub 2016 May 17.
3
GERD: An Alternative Perspective.胃食管反流病:另一种视角。
Traditional Chinese medicine based on Tongjiang methodology combined with proton pump inhibitor (PPI) step-down in treating non-erosive reflux disease: a study protocol for a multicentered, randomized controlled clinical trial.
基于通江法的中医药联合质子泵抑制剂(PPI)降阶梯治疗非糜烂性反流病的多中心随机对照临床研究方案
Trials. 2022 Oct 18;23(1):879. doi: 10.1186/s13063-022-06811-x.
4
Herbal Medicine Hewei Jiangni Decoction Is Noninferior to Oral Omeprazole for the Treatment of Nonerosive Gastroesophageal Reflux Disease: A Randomized, Double-Blind, and Double-Dummy Controlled Trail.中药和胃降逆汤治疗非糜烂性胃食管反流病不劣于口服奥美拉唑:一项随机、双盲、双模拟对照试验
Evid Based Complement Alternat Med. 2022 Sep 22;2022:9647003. doi: 10.1155/2022/9647003. eCollection 2022.
5
Herbal Medicine "Shulifenxiao" Formula for Nephrotic Syndrome of Refractory Idiopathic Membranous Nephropathy.中药“疏利分消”方治疗难治性特发性膜性肾病肾病综合征
Front Pharmacol. 2021 May 10;12:675406. doi: 10.3389/fphar.2021.675406. eCollection 2021.
6
A Methodological and Reporting Quality Assessment of Systematic Reviews/Meta-Analyses about Chinese Medical Treatment for Gastroesophageal Reflux Disease.关于中医治疗胃食管反流病的系统评价/荟萃分析的方法学与报告质量评估
Gastroenterol Res Pract. 2020 Sep 24;2020:3868057. doi: 10.1155/2020/3868057. eCollection 2020.
7
Efficacy of Chinese Herbal Formula Sini Zuojin Decoction in Treating Gastroesophageal Reflux Disease: Clinical Evidence and Potential Mechanisms.中药方剂四逆左金汤治疗胃食管反流病的疗效:临床证据与潜在机制
Front Pharmacol. 2020 Feb 27;11:76. doi: 10.3389/fphar.2020.00076. eCollection 2020.
8
Efficacy of High Specific Volume Polysaccharide - A New Type of Dietary Fiber - On Molecular Mechanism of Intestinal Water Metabolism in Rats With Constipation.高容积多糖——一种新型膳食纤维——对便秘大鼠肠道水代谢分子机制的影响。
Med Sci Monit. 2019 Jul 7;25:5028-5035. doi: 10.12659/MSM.916526.
9
Safety Evaluation of a New Traditional Chinese Medical Formula, Ciji-Hua'ai-Baosheng II Formula, in Adult Rodent Models.一种新型中药配方刺蒺藜-化艾-保生II号配方在成年啮齿动物模型中的安全性评价
Evid Based Complement Alternat Med. 2019 Jan 14;2019:3659890. doi: 10.1155/2019/3659890. eCollection 2019.
Psychosomatics. 2016 Mar-Apr;57(2):142-51. doi: 10.1016/j.psym.2015.10.007. Epub 2015 Oct 26.
4
Recurrence and Its Impact on the Health-related Quality of Life in Patients with Gastroesophageal Reflux Disease: A Prospective Follow-up Analysis.胃食管反流病患者的复发情况及其对健康相关生活质量的影响:一项前瞻性随访分析
J Neurogastroenterol Motil. 2016 Jan 31;22(1):86-93. doi: 10.5056/jnm15124.
5
Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis.在胃食管反流病的质子泵抑制剂治疗中添加促动力药:一项荟萃分析。
World J Gastroenterol. 2014 Mar 7;20(9):2412-9. doi: 10.3748/wjg.v20.i9.2412.
6
[Tongjiang granule intervened non-erosive reflux disease patients of Gan-Wei incoordination syndrome: a curative effect observation].通降颗粒干预肝胃不和证非糜烂性反流病患者的疗效观察
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Jul;33(7):915-9.
7
Guidelines for the diagnosis and management of gastroesophageal reflux disease.胃食管反流病诊断和管理指南
Am J Gastroenterol. 2013 Mar;108(3):308-28; quiz 329. doi: 10.1038/ajg.2012.444. Epub 2013 Feb 19.
8
A randomized, controlled, double-blinded and double-dummy trial of the effect of tongjiang granule on the nonerosive reflux disease of and Gan-Wei incoordination syndrome.通降颗粒治疗肝胃不和型非糜烂性反流病的随机、对照、双盲双模拟临床试验
Chin J Integr Med. 2011 May;17(5):339-45. doi: 10.1007/s11655-011-0724-0. Epub 2011 May 25.
9
Nonerosive Reflux Disease (NERD) - An Update.非糜烂性反流病(NERD)——更新。
J Neurogastroenterol Motil. 2010 Jan;16(1):8-21. doi: 10.5056/jnm.2010.16.1.8. Epub 2010 Jan 31.
10
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.系统评价与Meta分析优先报告条目:PRISMA声明
PLoS Med. 2009 Jul 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.